Connecting with an old partner in a new way.

In this issue of Cancer Cell, Hao and colleagues report a non-canonical interaction between the insulin receptor substrate 1 and certain oncogenic variants of the p110α catalytic subunit of phosphoinositide 3-kinase (PI3K). A cell-penetrant peptide that disrupts this interaction downregulates PI3K signaling and inhibits tumor growth in mice.